Sustained Viral Resilience
Funds R&D teams up to £8M to build durable, broad-spectrum antiviral medicines.
A consortium applies through one lead applicant, who receives the funding and subcontracts other members; even after a consortium is selected, ARIA can choose at the negotiation stage to fund only some of its workstreams or organisations rather than the whole team. Each proposal must sit within a single Technical Area — a project spanning Explorers, Accelerators and Translators needs a separate pr…
ARIA is funding research toward a new class of medicines, called sustained innate immunoprophylactics, that strengthen the body's innate immune system to give durable, broad-spectrum protection against respiratory viruses such as influenza and coronaviruses. The call funds three technical areas: Explorers building proof-of-concept candidates, Accelerators building tools, platforms and datasets to speed that work, and Translators working on clinical translation and future commercialisation.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from ARIA
All grants from this funder →ARIA Forecasting Tipping Points
ARIA · United Kingdom
Funds climate tipping-point early-warning work through ARIA's Scoping Our Planet programme.
ARIA Rolling Opportunity Seeds
🇬🇧ARIA · United Kingdom
Funds early United Kingdom proposals in artificial intelligence, climate, space, and neural interface exploration.
ARIA Robust Resilient Inference
ARIA · United Kingdom
Funds United Kingdom AI innovators with resilient inference programs and practical development support.
ARIA Safeguarded AI Programme
ARIA · United Kingdom
Funds United Kingdom AI ventures with safeguarded technology programs for responsible models.
ARIA Activation Partners RFP
🇬🇧ARIA · United Kingdom
Offers collaboration opportunities for United Kingdom organizations designing advanced activity hubs across strategic AI opportunity spaces.
Enduring Atmospheric Platforms RFP
🇬🇧ARIA · United Kingdom
Supports United Kingdom atmospheric platform research collaborations focused on resilient high-altitude communication infrastructure.
Similar grants
Browse the directory →
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Innovative Antimicrobials Against Resistant Pathogens
🇪🇺European Commission · European Union
Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.
Life Sciences Transformational R&D Investment Fund (TRIF) Pilot
🇬🇧DSIT · United Kingdom
Capital grants for large-scale UK life sciences R&D investments.
Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens
🇪🇺European Commission · European Union
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.